Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States: Hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, First Session
Coverage: Washington : U.S. Govt. Print. Off., 2008